Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy

NCT00387647 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Azacitidine

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]